Multiple Myeloma Turkish Prospective Patient Registry

Recruiting

• Conditions: Multiple Myeloma; Relapse Multiple Myeloma

• Registration Number: NCT04143932
• Lead Sponsor: Turkish Hematology Association

Brief Summary

This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey

Detailed Description

In this study, approximately from 40 centers 1000 patients will be recruited. All patients will be followed-up till the study end.

All the laboratory results, treatment protocols and responses will be recorded and assessed with EORTC Multiple Myeloma Specific Quality of Life Multiple Myeloma Specific (MY-20) and EORTC Quality of Life-C30 questionnaires.

Study Timeline

• Study First Submitted: 2019-10-27
• Study First Submitted QC: 2019-10-27
• Study First Posted: 2019-10-30
• Study Start: 2020-10-10
• Status Verified: 2023-07
• Last Update Submitted: 2023-07-15
• Last Update Posted: 2023-07-18
• Primary Completion: 2024-12
• Study Completion: 2024-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Diagnosed as multiple myeloma
• Patients signed informed consent form
• Patients received no more then 2 lines of therapy

Exclusion Criteria

• Patients below 18 years old

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression Free Survival	[Time Frame: 5 Years]	Time from the initiation of treatment to the death from any cause or progression
Overall Survival	[Time Frame: 5 Years]	Time from the diagnosis to the death

Trial Locations

Locations (1)

Medipol University; 🇹🇷 Istanbul, Turkey